Myocardial perfusion imaging in non-ischemic cardiomyopathy

  • Haren PatelEmail author
  • Shane Prejean
  • Ami E. Iskandrian
  • Fadi G. Hage
Images that Teach

Case Presentation

A 63-year-old African-American man was referred for exercise SPECT myocardial perfusion imaging (MPI) for the evaluation of non-exertional chest pain of 2-3 months duration that had worsened recently (occurring almost daily). He carries the diagnosis of dilated, non-ischemic cardiomyopathy (NICM) with left ventricular (LV) dysfunction by gated SPECT-MPI and 2-dimensional echocardiography (images not shown). His medication list is shown in Table  1.
Table 1

Baseline medication list

Aspirin 81 mg daily

Furosemide 40 mg daily

Carvedilol 25 mg twice daily

Irbesartan 300 mg daily

Digoxin 0.25 mg daily

Atorvastatin 20 mg daily

Potassium Chloride 10 mEq daily

Spironolactone 50 mg daily



All authors declare that they have no conflict of interest.

Supplementary material

12350_2018_1577_MOESM1_ESM.mp4 (1.1 mb)
Supplementary material 1 (MP4 1102 kb). Video 1: Gated splash images reveal diffuse wall motion/thickening abnormality, LV dilation and severely reduced left ventricular function (EF 27%)
12350_2018_1577_MOESM2_ESM.mp4 (999 kb)
Supplementary material 2 (MP4 999 kb). Video 2: Gated slice images reveal diffuse wall motion/thickening abnormality, LV dilation and severely reduced left ventricular function (EF 27%)


  1. 1.
    Danias PG, Papaioannou GI, Ahlberg AW, et al. Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy. Am J Cardiol. 2004;94:14–9.CrossRefGoogle Scholar
  2. 2.
    Caobelli F, Bengel FM. Ischaemic vs non-ischeamic dilated cardiomyopathy: the value of nuclear cardiology techniques. J Nucl Cardiol. 2015;5:971–4.CrossRefGoogle Scholar
  3. 3.
    Soman P, Lahiri A, Mieres JH, et al. Etiology and pathophysiology of new-onset heart failure: evaluation by myocardial perfusion imaging. J Nucl Cardiol. 2009;16:82–91. Scholar
  4. 4.
    Murthy V, Bateman T, Beanlands RS, et al. Clinical quantification of myocardial blood flow using PET: Joint Position Paper on the SNMMI Cardiovascular Council and the ASNC. J Nucl Med. 2018;59:273–93.CrossRefGoogle Scholar
  5. 5.
    McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–9.CrossRefGoogle Scholar
  6. 6.
    Richardson T, Kronenberg M. Reversible myocardial perfusion abnormalities in nonischemic dilated cardiomyopathy. J Nucl Cardiol. 2016;23:1183–5.CrossRefGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2019

Authors and Affiliations

  • Haren Patel
    • 1
    Email author
  • Shane Prejean
    • 1
  • Ami E. Iskandrian
    • 1
  • Fadi G. Hage
    • 1
    • 2
  1. 1.Division of Cardiovascular Disease, Department of MedicineUniversity of Alabama at BirminghamBirminghamUSA
  2. 2.Section of CardiologyBirmingham Veterans Affairs Medical CenterBirminghamUSA

Personalised recommendations